Genesis Merchant Capital

Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.

Babson Diagnostics, Inc. is a healthcare technology company based in Austin, Texas, focused on revolutionizing diagnostic blood testing by providing lab-quality results in retail settings such as pharmacies and grocery stores. Established in 2017, the company has developed an innovative device that collects blood samples from finger capillaries, requiring only a small volume—just one-tenth of that needed for traditional venipuncture methods. This approach allows for accurate diagnostic results to be obtained quickly, enhancing accessibility to essential health information for consumers. The samples are analyzed at CLIA-certified clinical laboratories, ensuring the reliability and quality of the testing process.